April 05, 2013, Friday
The author answers five questions on the disputed Novartis ruling
April 03, 2013, Wednesday
Brian Druker, who invented the drug's molecule, says it would benefit patients in the short term
April 02, 2013, Tuesday
In 2005, as the Indian Parliament debated at length the impact of complying with the WTO's TRIPS Agreement, one issue was ...
April 02, 2013, Tuesday
No one expected, when the first major clinical trial started on Glivec in 2000, that the patients would live much beyond a couple ...
April 02, 2013, Tuesday
"The judgement is indeed a landmark one because it empowers the common man and serves a social and national priority. In such ...
April 01, 2013, Monday
At Business-standard.com, we have often asked readers to respond to debatable issues on a designated space on the website called ...
April 01, 2013, Monday
The apex court verdict on Glivex has wide scale ramifications for multi-nationals operating in India. Meanwhile, the verdict will ...
March 29, 2013, Friday
Big Pharma is keenly waiting for the last word on the legal battle being waged in the Supreme Court over patent protection for ...
March 28, 2013, Thursday
Judgment on one of the most closely watched legal battles in the pharmaceutical industry is expected to be announced by the ...
March 27, 2013, Wednesday
Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week ...
September 06, 2012, Thursday
The outcome of the case will have huge ramifications.
January 19, 2008, Saturday
Swiss pharmaceutical giant Novartis is buoyant about growth prospects and further protection of intellectual property rights in ...
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
